174 related articles for article (PubMed ID: 28197072)
1. HMGB1 Mediates Autophagy Dysfunction via Perturbing Beclin1-Vps34 Complex in Dopaminergic Cell Model.
Huang J; Yang J; Shen Y; Jiang H; Han C; Zhang G; Liu L; Xu X; Li J; Lin Z; Xiong N; Zhang Z; Xiong J; Wang T
Front Mol Neurosci; 2017; 10():13. PubMed ID: 28197072
[TBL] [Abstract][Full Text] [Related]
2. Paraquat Inhibits Autophagy Via Intensifying the Interaction Between HMGB1 and α-Synuclein.
Wang K; Zhang B; Zhang B; Wu K; Tian T; Yan W; Huang M
Neurotox Res; 2022 Apr; 40(2):520-529. PubMed ID: 35316522
[TBL] [Abstract][Full Text] [Related]
3. Beclin1 and HMGB1 ameliorate the α-synuclein-mediated autophagy inhibition in PC12 cells.
Wang K; Huang J; Xie W; Huang L; Zhong C; Chen Z
Diagn Pathol; 2016 Jan; 11():15. PubMed ID: 26822891
[TBL] [Abstract][Full Text] [Related]
4. Corynoxine B targets at HMGB1/2 to enhance autophagy for
Zhu Q; Song J; Chen JY; Yuan Z; Liu L; Xie LM; Liao Q; Ye RD; Chen X; Yan Y; Tan J; Heng Tan CS; Li M; Lu JH
Acta Pharm Sin B; 2023 Jun; 13(6):2701-2714. PubMed ID: 37425041
[TBL] [Abstract][Full Text] [Related]
5. [Autophagic dysfunction contributes to α-synuclein accumulation in dopaminergic neurons induced by paraquat].
Wu KX; Yan WG; Tian T; Wang YF; Huang M
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2020 Mar; 38(3):180-186. PubMed ID: 32306690
[No Abstract] [Full Text] [Related]
6. Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease.
Sala G; Marinig D; Riva C; Arosio A; Stefanoni G; Brighina L; Formenti M; Alberghina L; Colangelo AM; Ferrarese C
Neurotoxicology; 2016 May; 54():161-169. PubMed ID: 27133439
[TBL] [Abstract][Full Text] [Related]
7. Corynoxine B ameliorates HMGB1-dependent autophagy dysfunction during manganese exposure in SH-SY5Y human neuroblastoma cells.
Yan D; Ma Z; Liu C; Wang C; Deng Y; Liu W; Xu B
Food Chem Toxicol; 2019 Feb; 124():336-348. PubMed ID: 30578841
[TBL] [Abstract][Full Text] [Related]
8. Rotenone impairs autophagic flux and lysosomal functions in Parkinson's disease.
Wu F; Xu HD; Guan JJ; Hou YS; Gu JH; Zhen XC; Qin ZH
Neuroscience; 2015 Jan; 284():900-911. PubMed ID: 25446361
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-(1-7) reduces α-synuclein aggregation by enhancing autophagic activity in Parkinson's disease.
Gao Q; Chen R; Wu L; Huang Q; Wang XX; Tian YY; Zhang YD
Neural Regen Res; 2022 May; 17(5):1138-1145. PubMed ID: 34558543
[TBL] [Abstract][Full Text] [Related]
10. Hydroxysafflor yellow A promotes α-synuclein clearance via regulating autophagy in rotenone-induced Parkinson's disease mice.
Han B; Wang L; Fu F; Wang Z; Zhang L; Qi GJ; Wang T
Folia Neuropathol; 2018; 56(2):133-140. PubMed ID: 30509033
[TBL] [Abstract][Full Text] [Related]
11. Geraniol Protects Against the Protein and Oxidative Stress Induced by Rotenone in an In Vitro Model of Parkinson's Disease.
Rekha KR; Inmozhi Sivakamasundari R
Neurochem Res; 2018 Oct; 43(10):1947-1962. PubMed ID: 30141137
[TBL] [Abstract][Full Text] [Related]
12. Death-associated Protein Kinase 1 Phosphorylates α-Synuclein at Ser129 and Exacerbates Rotenone-induced Toxic Aggregation of α-Synuclein in Dopaminergic SH-SY5Y Cells.
Shin WH; Chung KC
Exp Neurobiol; 2020 Jun; 29(3):207-218. PubMed ID: 32624505
[TBL] [Abstract][Full Text] [Related]
13. Cytosolic HMGB1 Mediates Autophagy Activation in an Emulsified Isoflurane Anesthesia Cell Model.
Liu RZ; Li T; Zhao GQ
Neurochem Res; 2019 May; 44(5):1090-1100. PubMed ID: 30712242
[TBL] [Abstract][Full Text] [Related]
14. High Mobility Group Box 1 Protein: A Plausible Therapeutic Molecular Target in Parkinson's Disease.
Goyal A; Agrawal A; Dubey N; Verma A
Curr Pharm Biotechnol; 2024; 25(8):937-943. PubMed ID: 37670710
[TBL] [Abstract][Full Text] [Related]
15. The molecular mechanism of rotenone-induced α-synuclein aggregation: emphasizing the role of the calcium/GSK3β pathway.
Yuan YH; Yan WF; Sun JD; Huang JY; Mu Z; Chen NH
Toxicol Lett; 2015 Mar; 233(2):163-71. PubMed ID: 25433145
[TBL] [Abstract][Full Text] [Related]
16. shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model.
Zharikov AD; Cannon JR; Tapias V; Bai Q; Horowitz MP; Shah V; El Ayadi A; Hastings TG; Greenamyre JT; Burton EA
J Clin Invest; 2015 Jul; 125(7):2721-35. PubMed ID: 26075822
[TBL] [Abstract][Full Text] [Related]
17. Drp-1 dependent mitochondrial fragmentation and protective autophagy in dopaminergic SH-SY5Y cells overexpressing alpha-synuclein.
Martinez JH; Alaimo A; Gorojod RM; Porte Alcon S; Fuentes F; Coluccio Leskow F; Kotler ML
Mol Cell Neurosci; 2018 Apr; 88():107-117. PubMed ID: 29414102
[TBL] [Abstract][Full Text] [Related]
18. VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease.
Tang FL; Erion JR; Tian Y; Liu W; Yin DM; Ye J; Tang B; Mei L; Xiong WC
J Neurosci; 2015 Jul; 35(29):10613-28. PubMed ID: 26203154
[TBL] [Abstract][Full Text] [Related]
19. A new perspective in Parkinson's disease, chaperone-mediated autophagy.
Li B; Zhang Y; Yuan Y; Chen N
Parkinsonism Relat Disord; 2011 May; 17(4):231-5. PubMed ID: 21215675
[TBL] [Abstract][Full Text] [Related]
20. HMGB1 is involved in autophagy inhibition caused by SNCA/α-synuclein overexpression: a process modulated by the natural autophagy inducer corynoxine B.
Song JX; Lu JH; Liu LF; Chen LL; Durairajan SS; Yue Z; Zhang HQ; Li M
Autophagy; 2014 Jan; 10(1):144-54. PubMed ID: 24178442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
